1. Home
  2. MYE vs EVO Comparison

MYE vs EVO Comparison

Compare MYE & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myers Industries Inc.

MYE

Myers Industries Inc.

HOLD

Current Price

$22.84

Market Cap

826.0M

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.07

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYE
EVO
Founded
1933
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
826.0M
934.1M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
MYE
EVO
Price
$22.84
$3.07
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$26.00
$7.00
AVG Volume (30 Days)
166.4K
98.7K
Earning Date
05-07-2026
04-08-2026
Dividend Yield
2.71%
N/A
EPS Growth
389.47
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$0.87
$1.37
Revenue Next Year
$1.83
$10.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.86
$2.31
52 Week High
$24.25
$4.80

Technical Indicators

Market Signals
Indicator
MYE
EVO
Relative Strength Index (RSI) 61.09 51.20
Support Level $20.03 $2.88
Resistance Level $24.03 $3.78
Average True Range (ATR) 0.92 0.12
MACD 0.22 -0.02
Stochastic Oscillator 67.89 29.41

Price Performance

Historical Comparison
MYE
EVO

About MYE Myers Industries Inc.

Myers Industries Inc designs, manufactures, and markets a variety of plastic, metal, and rubber products, including a broad selection of plastic reusable containers, pallets, small parts bins, bulk shipping containers, storage and organization products, OEM parts, custom plastic products, consumer fuel containers and tanks for water, fuel and waste handling. It operates through the following segments: The Material Handling segment manufactures a selection of durable plastic reusable products that are used repeatedly during the course of their service life. The Distribution segment is engaged in the distribution of equipment, tools, and supplies used for tire servicing and automotive under-vehicle repair, etc. It generates the majority of its revenue from the Material Handling segment.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: